Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia-Reference-Cited by-同舟云学术

Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia

Published:2022-12-15 Issue:1 Volume:36 Page:
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Kanninen Tomi¹²,Jung Eunjung¹²,Gallo Dahiana M.¹²³,Diaz-Primera Ramiro¹²,Romero Roberto¹⁴⁵⁶⁷,Gotsch Francesca¹²,Suksai Manaphat¹²,Bosco Mariachiara¹²,Chaiworapongsa Tinnakorn¹²

Affiliation:

1. Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, United States Department of Health and Human Services, Detroit, MI, USA

2. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA

3. Department of Gynecology and Obstetrics, Universidad del Valle, Cali, Colombia

4. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA

5. Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA

6. Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA

7. Detroit Medical Center, Detroit, MI, USA

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2022.2153034

Reference115 articles.

1. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia

2. Preeclampsia is associated with reduced serum levels of placenta growth factor

3. Circulating Angiogenic Factors and the Risk of Preeclampsia

4. First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

5. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukins IL33/ST2 and IL1-β in Intrauterine Growth Restriction and Seropositivity of Anti-Toxoplasma gondii Antibodies;Microorganisms;2024-07-12

2. Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening;International Journal of Molecular Sciences;2024-01-10

3. A mitochondrial regulator protein, MNRR1, is elevated in the maternal blood of women with preeclampsia;The Journal of Maternal-Fetal & Neonatal Medicine;2024-01-02

4. DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells;Endocrinology;2023-11-16

5. Th1 promotes M1 polarization of intestinal macrophages to regulate colitis-related mucosal barrier damage;Aging;2023-04-04